Skip to main content

Table 4 Primary and secondary outcomes

From: Enhanced PeriOperative Care and Health protection programme for the prevention of surgical site infections after elective abdominal surgery (EPO2CH): statistical analysis plan of a randomised controlled multicentre superiority trial

Characteristic

Intervention group (n =)

Control group (n =)

Relative risk (95% CI) ITT

Corrected relative risk (95% CI) PP

Corrected relative risk (95% CI) HP

Surgical site infections incidence within 30 days

     

Surgical site infections incidence within 90 days

     

Anastomotic leakage incidence within 30 days

     

Length of stay, median (IQR), d

     

Readmissions, median no. per patients (IQR)

     

Patients with Serious Adverse Events, no (%)

     

Serious adverse events, no

 Clavien Dindo III

     

 Clavien Dindo IV

     

 Clavien Dindo V

     

Quality adjusted life years

     
  1. ITT intention to treat population, IQR interquartile range+, PPP per-protocol population, HP harms population
Back to article page

Trials

ISSN: 1745-6215